Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral contraceptives.

Jessica R Oesterheld1, Kelly Cozza, Neil B Sandson

  • 1Department of Psychiatry of Maine Medical Center, VT, USA.

Psychosomatics
|March 21, 2008
PubMed
Summary
This summary is machine-generated.

Oral contraceptives (OCs) revolutionized birth control, but drug interactions were initially unclear. Advances in understanding drug metabolism, including P450 enzymes and phase II reactions, now allow for better assessment of these interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoinduction and suzetrigine: potential clinical implications.

Pain management·2026
Same author

Suzetrigine-Induced Metabolism of Factor Xa Inhibitors May Increase Risk of Thrombosis in Perioperative and Pain Patients.

Anesthesia and analgesia·2025
Same author

The pharmacokinetics of paliperidone versus risperidone.

Psychosomatics·2010
Same author

Capacity to give surgical consent does not imply capacity to give anesthesia consent: implications for anesthesiologists.

Anesthesia and analgesia·2010
Same author

Perioperative statin therapy may be implicated in a wide array of drug-drug interactions.

Anesthesiology·2009
Same author

A new pattern of buprenorphine misuse may complicate perioperative pain control.

Anesthesia and analgesia·2009
Same journal

Clinical Approach to Personality Change Due to Another Medical Condition.

Psychosomatics·2021
Same journal

Clonazepam for Catatonia Incompletely Responsive to lorazepam.

Psychosomatics·2021
Same journal

Diabetic Retinopathy and Depression: A Risk Assessment.

Psychosomatics·2021
Same journal

WITHDRAWN: Psychosis: A Presentation of COVID-19?

Psychosomatics·2021
Same journal

Dermatitis Neglecta, the Cognitive Assessment, and Micronutrients.

Psychosomatics·2020
Same journal

Coronavirus and Its Implications for Psychiatry: A Rapid Review of the Early Literature.

Psychosomatics·2020
See all related articles

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Contraception

Background:

  • Enovid, an early oral contraceptive, transformed birth control nearly 50 years ago.
  • Initial reports of drug interactions with oral contraceptives (OCs) lacked clear patterns.
  • Understanding of drug metabolism pathways has evolved significantly.

Purpose of the Study:

  • To review the historical context of oral contraceptive drug interactions.
  • To explain the role of P450 enzymes and phase II reactions in drug metabolism.
  • To assess the clinical relevance of drug interactions with OCs.

Main Methods:

  • Literature review of early and current reports on OC drug interactions.
  • Explanation of key drug metabolism enzymes (P450) and phase II reactions (sulfation, glucuronidation).

Related Experiment Videos

  • Categorization and assessment of the clinical significance of identified interactions.

    • Main Results:

    • Drug interactions with OCs were initially perceived as random.
    • Increased knowledge of P450 enzymes and phase II metabolic pathways provides a framework for understanding these interactions.
    • Preliminary categorization and assessment of clinical relevance are now possible.

    Conclusions:

    • The understanding of oral contraceptive drug interactions has advanced significantly.
    • Metabolic pathways involving P450 and phase II reactions are crucial for assessing interaction risks.
    • Current knowledge allows for a more informed clinical approach to managing OC drug interactions.